XML 50 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Income Taxes (Tables)
12 Months Ended
Sep. 27, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Before Provision For (Benefit From) Income Taxes
The Company’s income (loss) before provision for income taxes for fiscal 2025, 2024 and 2023 were as follows:
September 27,
2025
September 28,
2024
September 30,
2023
(In thousands)
Domestic$(70,672)$(56,661)$(9,904)
Foreign20,175 29,510 14,298 
Income (loss) before provision for income taxes$(50,497)$(27,151)$4,394 
Schedule of Provision For (Benefit From) Income Taxes
Components of the provision for income taxes consisted of the following:
September 27,
2025
September 28,
2024
September 30,
2023
(In thousands)
Current:
U.S. Federal$3,776 $8,094 $7,507 
U.S. State2,363 4,023 4,947 
Foreign4,500 17,798 2,810 
Total current10,639 29,915 15,264 
Deferred:
U.S. Federal— — — 
U.S. State— — — 
Foreign(18,920)(596)
Total deferred(18,920)(596)
Provision for income taxes$10,647 $10,995 $14,668 
Schedule of Deferred Tax Assets and Liabilities
Components of the Company’s deferred income tax assets and liabilities are as follows:
September 27,
2025
September 28,
2024
(In thousands)
Deferred tax assets
Capitalized research & development$131,858 $107,474 
Research & development tax credit carryforwards51,752 58,156 
Accrued expenses and reserves18,979 17,070 
Deferred revenue14,363 15,374 
Operating lease liability13,165 14,259 
Other capitalized costs12,448 12,030 
Stock-based compensation6,973 8,195 
Foreign net operating loss carryforwards5,293 5,783 
Depreciation4,098 2,991 
U.S. net operating loss carryforwards3,889 2,296 
Other370 592 
Total deferred tax assets263,188 244,220 
Valuation allowance(238,268)(216,365)
Deferred tax assets, net of valuation allowance24,920 27,855 
Deferred tax liabilities
Right-of-use asset(9,788)(10,955)
Intangibles(2,675)(3,392)
Capitalized inventory
(2,074)(3,254)
Total deferred tax liabilities(14,537)(17,601)
Net deferred tax assets
$10,383 $10,254 
Reported as
Deferred tax assets$10,509 $10,314 
Deferred tax liabilities(126)(60)
Net deferred tax assets
$10,383 $10,254 
Schedule of Changes in Valuation Allowance
The following table summarizes changes in the valuation allowance for fiscal 2025, 2024 and 2023:
September 27,
2025
September 28,
2024
September 30,
2023
(In thousands)
Beginning balance$216,365 $185,840 $162,267 
Increase during the period21,903 32,573 23,628 
Decrease during the period— (2,048)(55)
Ending balance$238,268 $216,365 $185,840 
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation of U.S. statutory federal income taxes to the Company’s provision for income taxes is as follows:
September 27,
2025
September 28,
2024
September 30,
2023
(In thousands)
U.S. federal income taxes at statutory rate$(10,604)$(5,702)$923 
U.S. state and local income taxes, net of federal benefit and state credits(4,619)(2,496)(841)
Foreign income tax rate differential991 1,544 734 
Stock-based compensation5,068 2,726 104 
Federal research and development tax credits(5,081)(8,240)(7,591)
Unrecognized federal tax benefits457 1,082 184 
Change in tax rate(190)(188)— 
Global intangible low taxed income, net of foreign tax credits715 944 1,234 
Foreign -derived intangible income (FDII) deduction(1,000)(1,519)(6,863)
Subpart F income697 733 1,374 
162(m) executive compensation limitation1,923 1,496 2,513 
Deferred adjustments— 504 — 
Intercompany IP sale— (10,412)— 
Other387 (121)(695)
Change in valuation allowance21,903 30,644 23,592 
Provision for income taxes$10,647 $10,995 $14,668 
Schedule of Changes in Unrecognized Tax Benefits
Change in gross unrecognized tax benefits, excluding interest and penalties, as a result of uncertain tax positions are as follows:
September 27,
2025
September 28,
2024
September 30,
2023
(In thousands)
Beginning balance$18,910 $17,619 $17,021 
Increase (decrease) - tax positions in prior periods
(207)147 (566)
Increase - tax positions in current periods904 1,144 1,164 
Ending balance$19,607 $18,910 $17,619